Skip to main content
Caplight Logo









Kebotix

Kebotix

Private
Cambridge, MassachusettsFrontier & Industrial Techhttps://www.kebotix.com/

Last Round

Series A

Extension

Aug 5, 2024

Est. Valuation

$25M

Total Funding Raised

$22.45M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Kebotix is a materials discovery company that provides a platform powered by artificial intelligence and robotics to accelerate the exploration, discovery, and production of new molecules and materials.

Sector

Frontier & Industrial Tech

Verticals

Advanced Materials, Drug Discovery, ML Platforms, Biotechnology

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

materials discoverygenerative AIautonomous laboratorymaterials informaticsAI-driven R&Dself-driving labchemical researchdrug discoverypredictive modelingactive learninglab automationSaaS platformAI for sciencedigital chemistryAI-first R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kebotix Comparables

Compare Kebotix with similar companies based on industry and business-model similarity.

Kebotix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Intellegens
86%
Sunthetics
86%
Atinary Technologies
85%

Kebotix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionAug 5, 2024
GrantDec 14, 2021
GrantJun 29, 2020
Series AApr 16, 2020
GrantSep 9, 2019
Seed
Nov 8, 2018

Key People

Founding team and executive leadership

Semion Saikin

Chief Operating Officer

Executive Team

Kebotix Investors

Notable investors and investment history

Kebotix investors
InvestorRounds
FlybridgeSeed
One Way VenturesSeries A, Seed
Constructor CapitalSeries A
Embark VenturesSeries A, Seed
Baidu VenturesSeries A, Seed
Propagator VenturesSeries A, Seed
Massachusetts Life Sciences CenterGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors grew 108% MoM, reaching 2.7K.

  • Aug 5, 2024

    $5M round raised

Kebotix Filings

Explore SEC and related filing metadata, where available.

Kebotix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Kebotix's valuation, stock price, and market status.

Is Kebotix a public or private company?

Kebotix is a private company.

What is the current stock price of Kebotix?

Kebotix is a private company with no public stock price. No recent secondary market data is available.

How much is Kebotix worth (valuation)?

Valuation information for Kebotix is not publicly available.

Can I buy Kebotix stock?

Kebotix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Kebotix's last funding round?

Kebotix's most recent funding round was Grant on December 14, 2021.

Who are the main investors in Kebotix?

Key investors in Kebotix include One Way Ventures, Novo Holdings.

Will Kebotix IPO soon?

No public IPO plans have been announced for Kebotix.

How can I track Kebotix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kebotix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range7
Year Founded2017
Last FundingAug 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?